thalidomide has been researched along with Central Serous Chorioretinopathy in 1 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Central Serous Chorioretinopathy: A visual impairment characterized by the accumulation of fluid under the retina through a defect in the retinal pigment epithelium.
| Excerpt | Relevance | Reference |
|---|---|---|
| "If patients have optic disc edema in both eyes with no intracranial space-occupying lesion, POEMS syndrome should be considered in differential diagnosis, regardless of age." | 1.40 | POEMS syndrome in a 20-year-old patient diagnosed following a complaint of reduced visual acuity. ( Doi, S; Hosogi, M; Hosokawa, M; Kawata, T; Kimura, S; Kondo, E; Morizane, Y; Shiode, Y; Shiraga, F, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, S | 1 |
| Kimura, S | 1 |
| Morizane, Y | 1 |
| Hosogi, M | 1 |
| Hosokawa, M | 1 |
| Shiode, Y | 1 |
| Kawata, T | 1 |
| Kondo, E | 1 |
| Shiraga, F | 1 |
1 other study available for thalidomide and Central Serous Chorioretinopathy
| Article | Year |
|---|---|
POEMS syndrome in a 20-year-old patient diagnosed following a complaint of reduced visual acuity.
Topics: Adult; Central Serous Chorioretinopathy; Combined Modality Therapy; Dexamethasone; Drug Therapy, Com | 2014 |